Kronos Advanced Technologies (OTC: KNOS), an innovation-driven product development company and creator of patented Kronos(R) CORE air disinfection technology inside its advanced smart air purification devices, today announced that the U.S. Food and Drug Administration (“FDA”) has recently granted 510(k) / Class II Medical Device clearance. According to the update, the FDA clearance was provided after a detailed review of the patented Model 5 device, which utilizes patented High Voltage Field air disinfection technology and is proven to eliminate 99.9% of harmful airborne particles, including allergens, bacteria, fungi, and viruses, like COVID-19. “We are proud that our manufacturer has been granted FDA clearance for the Model 5 Air Purifier, and we want to thank the FDA team for their investigation and test results review of Kronos CORE patented air disinfection technology,” said Michael Rubinov, CEO of Kronos. “We have been developing air disinfection and purification technology since 2002, and we are experts in indoor air quality. The recently approved FDA clearance of the Model 5 device, which is powered by our patented Kronos(R) air disinfection technology, represents a major step forward to marketing our products to hospitals, doctors’ offices, allergy suffers and areas where natural disasters occurred like when wildfires happen.”
To view the full press release, visit https://ibn.fm/p7ZcS
About Kronos Advanced Technologies Inc.
The company was initially founded in 2002 and funded by the U.S. military to develop electrostatic air movers. Eventually, the company moved into the consumer air purification business. It began operations as a product development company that invented and significantly changed the way air is moved, filtered and sterilized. Historically, Kronos has focused on developing, marketing and selling the company’s proprietary air movement and purification technology. Serving the indoor air quality (“IAQ”) market, Kronos technology uses state-of-the-art high-voltage patented processes without the use of traditional porous HEPA filters. Kronos-based products move air silently, filter, sterilize, and purify the air while dramatically reducing energy consumption to half of a 60-watt light bulb. Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled down for air purification in cars or scaled up in size for industrial and hazardous gas destruction. The technology is currently being implemented in multiple standalone products for businesses, homes and vehicles of all types — to move, sterilize and filter air, including removing allergens down to 14.6 nanometers, passing through its patented technology — replacing expensive outdated passive HEPA and other filtration type systems. There are broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices. Examples of immediately addressable markets include schools, universities, health care facilities, operating rooms, manufacturing clean rooms, and the cabins of automobiles and commercial aircraft. For more information, visit the company’s website at www.KronosATI.co.
NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://ibn.fm/KNOS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
